Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Clinical Trials01:16

Clinical Trials

6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

115
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
115
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

220
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
220
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

43
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
43
Sampling Plans01:23

Sampling Plans

165
Sampling is a crucial step in analytical chemistry, allowing researchers to collect representative data from a large population. Common sampling methods include random, judgmental, systematic, stratified, and cluster sampling.
Random sampling is a method where each member of the population has an equal chance of being selected for the sample. It involves selecting individuals randomly, often using random number generators or lottery-type methods. For example, when analyzing the properties of a...
165

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Novel Adipokine, FAM19A5, Inhibits Neointima Formation After Injury Through Sphingosine-1-Phosphate Receptor 2.

Circulation·2018
Same author

Liquid-Crystalline Dynamic Networks Doped with Gold Nanorods Showing Enhanced Photocontrol of Actuation.

Advanced materials (Deerfield Beach, Fla.)·2018
Same author

KCa(H<sub>2</sub> O)<sub>2</sub> [Fe<sup>III</sup> (CN)<sub>6</sub> ]⋅H<sub>2</sub> O Nanoparticles as an Antimicrobial Agent against Staphylococcus aureus.

Angewandte Chemie (International ed. in English)·2018
Same author

Warming deferentially altered multidimensional soil legacy induced by past land use history.

Scientific reports·2018
Same author

Advanced Modified Polyacrylonitrile Membrane with Enhanced Adsorption Property for Heavy Metal Ions.

Scientific reports·2018
Same author

Insulin-like growth factor 2 is a key mitogen driving liver repopulation in mice.

Cell death & disease·2018

相关实验视频

Updated: May 30, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K

在多区域临床试验 (MRCT) 中数据聚合策略的基本考虑

Jiali Song1, Chen Ji2, Meng Chen3

  • 1Department of Biostatistics, School of Public Health, Peking University, Beijing, China.

Therapeutic innovation & regulatory science
|January 25, 2025
PubMed
概括

本研究解决了中国多区域临床试验 (MRCT) 的挑战,重点关注全球药物开发的策略,效果修饰剂和统计分析. 它为协调中国和东亚的MRCT实践提供了见解.

关键词:
效果修饰器的效果修饰器在ICH E1717中.聚合策略策略 聚合策略样本大小分配的分配

更多相关视频

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

16.5K

相关实验视频

Last Updated: May 30, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

16.5K

科学领域:

  • 临床药理学 临床药理学
  • 监管科学 监管科学
  • 生物统计学 生物统计学

背景情况:

  • 中国国家医疗药品管理局正在采用ICH E17指南,用于多区域临床试验 (MRCT).
  • 中国和东亚的MRCT的执行和进行面临着关于聚合,效果修饰器和统计分析的模两可.
  • 与全球试验标准的调整为区域药物开发带来了挑战.

研究的目的:

  • 在中国背景下探索规划和开展MRCT的标准.
  • 解决聚合策略,效果调整因子 (EMs) 的识别,统计分析和样本大小分配的模糊性.
  • 为国内和国际MRCT实践的改进提供见解.

主要方法:

  • 确定内在和外在因素作为潜在的效果修饰剂 (EMs),影响特定人群中的药物疗效.
  • 实施区域聚合策略,评估东亚地区人口差异,当没有确定EM时.
  • 使用统计模型来估计药物对聚合群体的影响.

主要成果:

  • 定义了为MRCTs在中国人群中确定效果修饰剂的标准.
  • 概述了区域聚合和统计分析的策略,在没有确定EMS的情况下.
  • 澄清了东亚MRCT的样本大小分配考虑因素.

结论:

  • 这篇论文详细介绍了中国的MRCT实践,解决了审判执行的关键挑战.
  • 为协调国内和国际MRCT提供实用见解.
  • 旨在改善该地区未来的多区域临床试验的规划和进行.